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Free radicalse effects of curcumin in cardiac cells subjected to a protocol simulating ischemia-
reperfusion (IR). Curcumin (10 μM) was administered before ischemia (pretreatment) or at the moment of
reperfusion (posttreatment) and its effects were compared to those produced by a reference antioxidant
(Trolox) with an equal antioxidant capacity. IR cardiac cells showed clear signs of oxidative stress, impaired
mitochondrial activity, and a marked development of both necrotic and apoptotic processes; at the same
time, increases in NF-κB nuclear translocation and JNK phosphorylation were observed. Curcumin
pretreatment was revealed to be the most effective in attenuating all these modifications and, in particular,
in reducing the death of IR cells. This confirms that the protective effect of curcumin is not related simply to
its antioxidant properties but involves other mechanisms, notably interactions in the NF-κB and JNK
pathways. These findings suggest that curcumin administration, in particular before the hypoxic challenge,
represents a promising approach to protecting cardiac cells against IR injury. In this scenario our results point
out the importance of the chronology for the outcome of the treatment and provide a differential valuation of
the degree of protection that curcumin can exert by its antioxidant activity or by other mechanisms.
© 2008 Elsevier Inc. All rights reserved.Ischemia-reperfusion (IR) injury, a condition that plays an
important role in several circumstances of clinical interest, is multi-
factorial, but it is generally accepted that an excessive production of
reactive oxygen species (ROS) plays a prominent role in its develop-
ment [1]. In heart muscle IR has been found to induce myocyte
necrosis and apoptosis that seem to be the prevalent mode of death
during, respectively, the ischemic period and the reperfusion [2–4].
The intracellular signaling pathways leading to cardiomyocyte death
in IR are poorly understood; however, there is evidence that the
nuclear factor κB (NF-κB), a pivotal transcription factor [5], is rapidly
activated by ischemia in several tissues, including myocardium [6]. In
the inactive state NF-κB is present in the cytoplasm as a heterotrimeric
complex consisting of two subunits and an additional inhibitory
subunit: IκBα. During the activation process, the inhibitory subunit is
phosphorylated in Ser 32 and Ser 36 residues by IKK (IκBα kinase) and
is subsequently degraded. Once released, subunits of activated NF-κB
translocate to the nucleus and activate the expression of selected
target genes, among them those involved in cell death pathways [7].
Another pathway that might have a part in cardiomyocyte death
during IR is that related to the c-Jun N-terminal kinase (JNK), which
represents one of the “stress-responsive” members of the mitogen-l rights reserved.activated protein kinase (MAPK) family [8]. A variety of stress stimuli,
including oxidative stress, can induce JNK phosphorylation and the
consequent activation of this pathway that, by wide consent, is
associated with apoptosis [9].
Obviously, antioxidant treatments have a very important role in
cell protection against IR injury and many substances have been
proposed for this purpose. In the past years growing interest has been
addressed to curcumin, a major active component of the food flavor
turmeric, which is extracted from the powdered dry rhizome of Cur-
cuma longa Linn (Zingiberacee), a perennial herb widely cultivated in
tropical regions of Asia. Curcumin, used as a spice to give the specific
flavor and yellow color to curry, has been employed for centuries in
indigenous medicine for the treatment of a variety of diseases [10].
Several studies in recent years have shown that curcumin is an
inhibitor of tumor initiation in vivo [11] and possesses antiprolifera-
tive activity against tumor cells in vitro [12]. In addition to these
anticarcinogenic properties, curcumin seems to be, even at relatively
low concentrations, an effective anti-inflammatory agent [13,14].
Although the exact mechanism by which curcumin promotes these
effects remains to be elucidated, the antioxidant properties of this
substance seem to be an essential component underlying its
pleiotropic biological activities. Curcumin, in fact, has been reported
to inhibit lipid peroxidation and to effectively scavenge superoxide
anion and hydroxyl radicals. In addition to this antioxidant ability,
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animal models have shown that this effect was associated with a
protection against various stressing conditions [15].
These observations caused us to perform the present study, aimed
at assessing the effectiveness of curcumin in protecting cardiac cells
from IR injury and to explore themolecularmechanism(s) of its action.
In particular, we intended to establish if the effects of curcumin were
ascribable solely to its antioxidant properties or also to other
mechanisms, notably to possible interactions in the NF-κB- and/or
JNK-related pathways. To this end the effects of curcumin on cultured
cardiomyoblasts subjected to simulated IR were compared to those
produced, at a parity of antioxidant capacity, by Trolox, the well-
known water-soluble analogue of vitamin E.
Materials and methods
Cell cultures
Rat heart myoblasts (line H9c2 (2-1) n. 88092904, purchased from
the European Collection of Cell Cultures) were plated at a density of
5×105/100-mm plate and cultured at 37°C in a humidified atmo-
sphere with 5% CO2 in Dulbecco's modified Eagle's medium
supplemented with 10% heat-inactivated fetal bovine serum, 1%
penicillin, 1% streptomycin, and 1% L-glutamine. Cells were passaged
regularly and subcultured to ∼90% confluence before experimental
procedures. Curcumin, Trolox, Bay 11-7082, and SP600125 were
purchased from Sigma. All other reagents were of the highest purity
available.
Simulated ischemia-reperfusion protocol and cell treatment
Hypoxic challenge was achieved by using a modular incubator
chamber (Billups-Rothenberg, Inc., CA, USA) gassed with 95% N2, 5%
CO2. A flow meter was used to measure the quantity of gas mixture
introduced into the chamber (25 L/min) according to Namiki et al. [16].
To simulate IR, after incubation under hypoxic conditions and in
serum and glucose-free medium for 24 h, the cells were reoxygenated
by immediate replacement of fresh complete culture medium and
were returned to a normoxic environment at 37°C for 60 min. Cell
treatment was induced 1 h before the hypoxic challenge or at the
moment of reoxygenation by adding curcumin or Trolox at concen-
trations of respectively 10 and 25 μM, which we found to display the
same antioxidant capacity (see below). To check for possible toxic
effects of these compounds the normoxic control H9c2 cells were also
subjected to the same treatments. In another series of experiments
aimed at exploring the contribution of NF-κB and JNK pathways in this
experimental model, cells were treated for 1 h before hypoxia with
10 μM Bay 11-7082 (specific inhibitor of NF-κB) or 10 μM SP600125
(specific inhibitor of JNK).
Preparation of cell homogenates
H9c2 cells (1×106) were washed twice with phosphate-buffered
saline (PBS), trypsinized, collected by centrifugation, and then
resuspended in 100 μl of lysis buffer containing 1% Triton X-100,
20 mM Tris-HCl, pH 8, 137 mM NaCl, 10% (v/v) glycerol, 2 mM EDTA,
and 6 M urea supplemented with 0.2 mM PMSF as well as 10 μg/ml
leupeptin and aprotinin. To obtain cellular homogenates, samples,
after three freeze-thaw cycles, were sonicated twice in ice for 5 s and
centrifuged at 14,000g for 10 min at 4°C. The supernatant was then
collected. Protein content was measured by the Bradford method [17].
Determination of intracellular ROS
Cells were cultured on a 96-well plate and after hypoxia dye
loading was achieved by adding to the cell culture medium the ROS-sensitive fluorescent probe CM-H2DCFDA dissolved in 0.1% DMSO
(2.5 μM) and pluronic acid F-127 (0.01% w/v) for 10 min at 37°C. The
CM-H2DCFDA esterified derivative is loaded more effectively within
the cytoplasm of the cells because it is more cell permeant before the
ester groups are hydrolyzed by the cellular esterases. Only a negligible
leakage of the probe occurred, because chloromethyl-DCF is nega-
tively charged at physiological intracellular pH. Fluorescence intensity
was analyzed by a fluorescence reader (Fluoroscan Ascent FL,
Labsystems, Finland) using a 485-nm excitation and 538-nm emission
filter.
Total antioxidant capacity (TAC)
Intracellular TAC, accounting for total hydrophilic ROS scavengers,
was measured in cell lysates by a chemiluminescence assay using the
photoprotein Pholasin (Abel Antioxidant Test Kit, Knight Scientific Ltd,
UK). After being washed with PBS, cells were resuspended in 20 mM
Tris-HCl buffer, pH 8, containing 1.0% Triton, 137 mM NaCl, 10%
glycerol, 6.0 M urea, 0.1 mM PMSF, 10 μg/ml leupeptin, and 10 μg/ml
aprotinin before storage at −80°C until use. Cell plasma membranes
were broken by three freeze-thaw cycles, 5.0 s sonication in ice, and
centrifugation at 14,000g for 10 min at 4.0°C. Protein content was
measured by the Bradford method [17]. The results were calculated
using an L-ascorbic acid-based standard curve. The above chemilumi-
nescence assay was used, in an in vitro assay, to assess the antioxidant
capacity of curcumin and Trolox.
Lipid peroxidation
To assess the rate of lipid peroxidation, isoprostane levels were
measured in cell lysates using the 8-isoprostane EIA kit (Cayman
Chemical Co., Ann Arbor, MI, USA) following the manufacturer's
instructions. Lipid peroxidation was also investigated by confocal
scanning microscopy analysis, using the fluorescent probe BODIPY,
which is intrinsically lipophilic, thus mimicking the properties of
natural lipids [18]. In particular, BODIPY 581/591 C11 acts as a
fluorescent lipid peroxidation reporter that shifts its fluorescence
from red to green when challenged with oxidizing agents. Briefly,
cells were cultured on glass coverslips and dye loading was
achieved by adding to the cell culture medium the fluorescent
probe BODIPY dissolved in 0.1% DMSO (5 μM final concentration) for
30 min at 37°C. The cells were fixed in 2.0% buffered paraformalde-
hyde for 10 min at room temperature and the BODIPY fluorescence
was analyzed using the confocal Leica TCS SP5 scanning microscope
(Mannheim, Germany) equipped with an argon laser source for
fluorescence measurements, using a 581-nm excitation wavelength.
The observations were performed by collecting the emitted
fluorescence with a Leica Plan Apo 63×oil immersion objective.
A series of optical sections (1024×1024 pixels) 1.0 μm in thickness
was taken through the cell depth at intervals of 0.5 μm. A
number of optical sections ranging from 10 to 20 for each exa-
mined sample were then projected as a single composite image by
superimposition.
Mitochondrial activity assay
Mitochondrial activity was assessed by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in a 96-well plate
[19]. After the cells were washed with PBS, 100 μl of 0.5 mg/ml MTT
solution in PBS was added to the cell cultures and the samples were
incubated for 4.0 h at 37°C. Finally, 100 μl of cell lysis buffer (20% SDS,
50% N,N-dimethylformamide, pH 4.7) was added to each well and the
samples were incubated for at least 3 h at 37°C in a humidified
incubator before determination of absorbance of blue formazan at
590 nm with an ELISA plate reader. Cell viability was expressed as
percentage of MTT reduction.
Fig. 1. Effects of curcumin and Trolox pretreatment on intracellular ROS production in IR
H9c2 cells at various times of reoxygenation. ROS concentration was measured by CM-
H2DCFDA fluorescence and expressed as fold increase with respect to the control value
indicating ROS levels in normoxic control cells. For details, see Materials and methods.
All values (means±SD) are representative of five independent experiments, each carried
out in triplicate.
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LDH activity was assessed spectrophotometrically in the culture
medium and in adherent cells (to obtain total LDH content) using theFig. 2. (A) Rate of lipid peroxidation as measured as cytosolic level of 8-isoprostanes accordin
independent experiments carried out in triplicate. °Significant difference (p≤0.05) vs con
microscopy images of lipid peroxidation in IR H9c2 cells loaded with the fluorescent probe
equivalent units, was measured by a chemiluminescence assay in the cytosolic fractions of the
the hypoxic challenge.LDH assay kit (Roche Diagnostics, Mannheim, Germany). LDH release
was calculated as a percentage of total LDH content.
Assessment of cell death
Mitochondrial permeability was measured by calcein fluorescence
according to the method of Petronilli et al. [20] with minor
modifications. In brief, calcein/AM freely enters the cell and becomes
fluorescent upon deesterification. Coloading of cells with cobalt
chloride quenches the fluorescence in the cell except in the
mitochondria, because cobalt cannot cross mitochondrial membranes
(living cells). During induction of the MPTP (Mitochondrial Perme-
ability Transition Pore) opening cobalt can enter the mitochondria,
where it is able to quench calcein fluorescence (apoptotic cells). Thus,
decreased mitochondrial calcein fluorescence can be taken as a
measure of the extent of MPTP induction. The detection of necrotic
cells was performed by staining with propidium iodide. Cells were
cultured on glass coverslips and dye loading was achieved by adding
to the cell culture medium the fluorescent probes calcein /AM (3 μM),
propidium iodide solution (5 μM), and cobalt chloride (1 mM) for
20 min at 37°C.
After cobalt quenching, cells were washed with PBS and fixed in
2.0% buffered paraformaldehyde for 10 min at room temperature and
the fluorescence was analyzed using the confocal Leica TCS SP5
scanning microscope equipped with an argon laser source for
fluorescence measurements, using 488-nm and 543-nm excitationg to Materials and methods. The reported values (means±SD) are representative of five
trol (C) cells. ⁎Significant difference (p≤0.05) vs IR cells. (B) Representative confocal
BODIPY according to Materials and methods. (C) Cellular TAC, expressed in ascorbate
lysates of IR H9c2 cells exposed or not to 10 μM curcumin or 25 μMTrolox for 1 h before
Fig. 3.Mitochondrial activity in IR H9c2 cells. (A) Mitochondrial activity was checked by
the MTT test in cells exposed or not to 10 μM curcumin or 25 μM Trolox for 1 h. Values
are expressed as a percentage vs control (C) cells. The reported values (means±SD) are
representative of five independent experiments, each performed in triplicate.
°Significant difference (p≤0.05) vs control (C) cells. ⁎Significant difference (p≤0.05) vs
IR cells. (B) The release of cellular LDH into the culture medium of IR H9c2 cells treated
or not with 10 μM curcumin or 25 μM Trolox for 1 h was measured using a
spectrofluorimeter. LDH releasewas calculated as a percentage of total LDH content. The
reported values (means±SD) are representative of five independent experiments, each
performed in triplicate. ⁎Significant difference (p≤0.05) vs IR cells. #Significant
difference (p≤0.05) vs curcumin-pretreated (Cur pre) cells.
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emitted fluorescence with a Leica Plan Apo 63×oil immersion
objective. A series of optical sections (1024×1024 pixels) 1.0 μm in
thickness was taken through the cell depth at intervals of 0.5 μm. A
number of optical sections ranging from 10 to 20 for each examined
sample were then projected as a single composite image by
superimposition.
Caspase-3, caspase-8, and caspase-9 activity
Cells were cultured on glass coverslips and the culture medium
was removed and replaced with FAM-FLICA caspase-3 and -7
solution (Caspase 3 and 7 FLICA kit FAM-DEVD-FMK; Immuno-
chemistry Technologies, Bloomington, MN, USA), FAM-FLICA cas-
pase-8 solution (Caspase 8 FLICA kit FAM-LETD-FMK), and FAM-
FLICA caspase-9 solution (Caspase 9 FLICA kit FAM-LEHD-FMK), for
1 h, following the manufacturer's instructions. Cells were washed
three times with a wash buffer provided by the kit and fixed in
2.0% buffered paraformaldehyde for 10 min at room temperature.
Fluorescence was detected using the confocal Leica TCS SP5
scanning microscope equipped with an argon laser source for
fluorescence measurements, using 488-nm excitation wavelength.
The observations were performed by collecting the emitted
fluorescence with a Leica Plan Apo 63×oil immersion objective.
A series of optical sections (1024×1024 pixels) 1.0 μm in thickness
was taken through the cell depth at intervals of 0.5 μm. A number
of optical sections ranging from 10 to 20 for each examined
sample were then projected as a single composite image by
superimposition.
NF-κB nuclear translocation assessment by Western blot
To assess the protein levels of NF-κB, equal amounts of nuclear
fraction (60 μg) were diluted in Laemmli's sample buffer with 6 M
urea and boiled at 65°C for 5 min. Proteins were separated on 10%
SDS-PAGE and were transferred to PVDF Hybond membrane
(Millipore Corp., Billerica, MA, USA). The membrane was then
incubated overnight at 4°C with a highly specific (mouse) anti-
NF-κB (p50 subunit; sc-8414) monoclonal antibody (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA). After being washed, the
membrane was incubated with peroxidase-conjugated secondary
antibodies for 1 h. Then immunolabeled bands were detected using
a SuperSignal West Dura (Pierce, Rockford, IL, USA) and quantified
by densitometry analysis using a Chemi Doc system and Quantity
One software (Bio-Rad Laboratories, Hercules, CA, USA). Results
were expressed as ratios between the densitometry of the protein of
interest and that of the loading control (histone H1; highly specific
anti-histone H1 antibodies were purchased from Abcam plc,
Cambridge, UK).
JNK levels
H9c2 cardiac cells were grown to 80% confluence in 96-well tissue
culture plates and then subjected to the above-described procedure in
the presence or absence of curcumin or Trolox. After cell fixation by 4%
formaldehyde in PBS, total JNK and phosphorylated JNK were
quantified using a commercially available assay (JNK ELISA kit; FACE,
Active Motif Europe, Rixensart, Belgium), according to the manufac-
turer's instructions.
Statistical analysis
All data are expressed as means±SEM. Comparisons between
the different groups were performed by ANOVA followed by
Bonferroni t test. A p value of b0.05 was accepted as statistically
significant.Results
ROS production and oxidative-stress markers in IR cells
Compared to the control cells, IR cardiac cells exhibited a
significant increase in ROS cellular levels. As indicated by the DCFH-
DA fluorescence, this increase started at 5 min of reoxygenation
and reached a peak at 10 min; at 60 min control levels were
restored (Fig. 1). After 60 min of reoxygenation, the concentration
of 8-isoprostanes (typical stable end products of the lipoperox-
idative process) was significantly higher in the IR than in the
control cells (Fig. 2A) and concordant results were obtained using
the fluorescent lipid probe BODIPY 581/591 C11 (Fig. 2B).
Concomitant with the increased levels of oxidative-stress markers,
TAC, assayed as an index of the antioxidant defenses, was
significantly reduced (Fig. 2C). When curcumin and Trolox treat-
ments were performed before the beginning of the ischemic phase
(pretreatment) they produced significant changes in the above
parameters: treated IR cardiac cells, in fact, exhibited lower
increases in ROS cellular levels, reduced levels of oxidative stress
markers, and a higher TAC compared to the corresponding
untreated cells. On the other hand, when curcumin and Trolox
were added at the moment of the reperfusion (posttreatment) they
were revealed to be less effective in reducing oxidative stress
markers, although the TAC levels were higher than those observed
in the pretreatments.
Fig. 4. Representative confocal microscopy images showing IR H9c2 cell outcome. (A) Apoptotic and necrotic cells were imaged by using calcein (green) and PI (red) as fluorescent
probes, respectively. Cells were coloaded with CoCl2. The activation of the apoptotic programwas assessed bymeasuring fluorescence changes in (B) caspase-3, (C) caspase-8, and (D)
caspase-9 activity. For details, see Materials and methods. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 5. Western blot analysis of NF-κB All signals were quantified by densitometric
analysis and are expressed as the ratio of NF-κB densitometry to Histone H1 (loading
control) densitometry. Each bar represents the mean±SEM of five different blots and
relative densitometric quantifications. °Significant difference (p≤0.05) vs control (C)
cells. ⁎Significant difference (p≤0.05) vs IR cells. #Significant difference (p≤0.05) vs
curcumin-pretreated (Cur pre) cells.
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The results of the MTT reduction test (Fig. 3A) indicate that
mitochondrial activity was significantly reduced in IR cardiac cells
compared to the control cells. Curcumin pretreatment almost
suppressed this effect; in contrast, with the other treatments
(curcumin posttreatment, Trolox pre- and posttreatment) the mito-
chondrial activity of IR cells, though improved, was always signifi-
cantly lower compared to the control level.
LDH release in the culture medium (Fig. 3B), a finding that is
considered to account for cell mortality and, especially for necrotic
death, was markedly and significantly increased by the IR conditions
used in the present study. LDH release was significantly reduced by all
treatments; but also in this case the pretreatment with curcumin,
resulting in about 50% of the level observed for the untreated IR cells,
proved to be the most effective. These results agree with those
provided by confocal microscopy analysis using the calcein/PI staining.
As is evident from the images shown in Fig. 4A, the pretreatment with
curcumin induced the most marked reduction in the number of the
necrotic and apoptotic cells.
Confocal analysis was also used for a quali-quantitative assessment
of the apoptotic processes, based on the changes in fluorescence
associated with the activation of caspase-3, -8, and -9. The images in
Figs. 4B, 4C, and 4D show a marked activation of caspase-3 and -9 in
our IR cells and indicate curcumin pretreatment as the most effective
in attenuating this effect.
NF-κB nuclear translocation and JNK activation: occurrence and role in
the outcome of IR cells
With respect to the control cells, IR cardiac cells exhibited more
than threefold higher nuclear levels of NF-κB (Fig. 5) and a significant
increase in the ratio between the phosphorylated and the unpho-
sphorylated forms of JNK (pJNK/JNK; Fig. 6). These effects, indicative of
an activation of the related signaling pathways, were significantly
reduced by all the treatments performed in the present study, butcurcumin pretreatment was the most effective. Only this treatment, in
fact, was able to reduce nuclear NF-κB and the pJNK/JNK ratio to levels
that did not significantly differ from the control value and were
comparable to those produced by Bay 11–7082 and SP600125 at
concentrations of 10 μM, which are known to completely inhibit these
processes (Figs. 7A and 7B).
Fig. 8 shows the results of experiments aimed at quantifying the
roles of NF-κB and JNK in the outcome of IR cells and, at the same time,
providing information about the mechanism(s) underlying the
beneficial effect of curcumin. As judged by the LDH release, the
combined effects of Bay 11–7082 and SP600125 significantly
decreased, by about 20%, cell death in IR cells. When curcumin and
Trolox pretreatments were performed in the presence of these
Fig. 6. Quantification of total and phosphorylated c-Jun N-terminal kinase in IR H9c2 cardiac cells. The reported values (means±SD) are representative of five independent
experiments, each performed in triplicate. °Significant difference (p≤0.05) vs control (C) cells. ⁎Significant difference (p≤0.05) vs IR cells. #Significant difference (p≤0.05) vs
curcumin-pretreated (Cur pre) cells.
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but this effect was less marked for curcumin treatment: as a result, no
significant difference was found under these conditions between the
two treatments.Fig. 7. (A)Western blot analysis of NF-κB activation in IR cardiac cells treated or not with
10 μM curcumin or 25 μM Trolox in the presence or absence of Bay 11–7082. All signals
were quantified by densitometric analysis and are expressed as the ratio of NF-κB
densitometry to histone H1 (loading control) densitometry. Each bar represents the
mean±SEM of five different blots and relative densitometric quantifications.
°Significant difference (p≤0.05) vs control (C) cells. ⁎Significant difference (p≤0.05) vs
IR cells. #Significant difference (p≤0.05) vs curcumin-pretreated (Cur pre) cells. (B)
Quantification of total and phosphorylated c-Jun N-terminal kinase in IR H9c2 cardiac
cells treated with SP600125. The reported values (means±SD) are representative of five
independent experiments, each performed in triplicate. °Significant difference (p≤0.05)
vs control (C) cells. ⁎Significant difference (p≤0.05) vs IR cells. #Significant difference
(p≤0.05) vs curcumin-pretreated (Cur pre) cells.Effects of curcumin and Trolox on control cells
As illustrated in Figs. 2, 3, 5, and 6, curcumin and Trolox were
added, at the same concentrations used for the treatments of IR cells,
to the control normoxic cardiac cells to verify a possible direct effect of
these substances on the considered parameters, independent of the IR
conditions: no significant changes were observed in the control cells,
except for an expected increase in their total antioxidant capacity. Bay
11–7082 and SP600125, when added to control cells at the same
concentrations used during the experiments, revealed no toxic effects
(no LDH release), as shown in Fig. 8.
Discussion
Curcumin has been found to possess a variety of pharmacological
and biological activities [10], and a particular interest in this
substance, in view of a potential clinical employment, comes from
the fact that it is a nontoxic and nonmutagenic natural product. It has
been recently demonstrated that a 1–15 μM concentration of
curcumin does not cause cytotoxicity [21]. The use of curcumin as a
therapeutic agent has been investigated in a number of pathological
conditions, including cardiovascular diseases and other vascular
dysfunctions [22,23]. Several recent reports also indicate that
curcumin can attenuate the damages induced by postischemic
reperfusion in various tissues and under various experimentalFig. 8. Release of cellular LDH into the culture medium of IR H9c2 cells treated or not
with 10 μM curcumin or 25 μM Trolox in the presence or absence of Bay 11–7082 and
SP600125. LDH release was calculated as a percentage of total LDH content. The
reported values (means±SD) are representative of five independent experiments, each
performed in triplicate. ⁎Significant difference (p≤0.05) vs IR cells. #Significant
difference (p≤0.05) vs curcumin-pretreated (Cur pre) cells.
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strong antioxidant activity of curcumin [27], a substance that we
found (data not shown) to have a free radical scavenging activity more
then twice as highwith respect toTrolox, a compound commonly used
as a standard in this kind of measurement.
To verify the effectiveness of curcumin in protecting cardiac cells
against IR injury we examined the effects of two different treatments
with this substance (the above-described pre- and posttreatment) on
H9c2 cardiac cells subjected to a well-established protocol of
simulated IR. H9c2 cells are extensively used in cardiologic research
because they have been found to possess elements and properties of
signaling pathways of the adult myocyte [28]; thus we thought that
this was a suitable model for the purposes of this study. In both
treatments the final curcumin concentration in the culture medium
was 10 μM, a level that was confirmed to be devoid of cytotoxicity by
our results and did not induce significant changes in the MTT test nor
in LDH release with respect to the untreated control cells. Ten
micromolar is a concentration frequently used for curcumin in studies
with cultured cells and it is on the same order of magnitude as the
levels that may be achieved from dietary intake. According to a recent
report on this subject [29] a concentration of 3.6 μM is reached in
human serumwith a curcumin oral administration of 8 g/day, but this
compound is safe even at higher doses (12 g/day) and its bioavail-
ability may be improved by several approaches, such as the use of an
adjuvant like piperine or the use of liposomal curcumin or curcumin
nanoparticles.
Our measurements were intended to establish: (i) the occurrence
and the intensity of oxidative stress; (ii) the effects on cellular
viability, including the assessment of necrotic and apoptotic cell
death; and (iii) a possible involvement of the signaling pathways
related to NF-κB and JNK, because their activation in response to
oxidative stress may result in cell apoptosis/necrosis. To see whether
the effects of curcumin were to be ascribed only to its antioxidant
activity, all the above determinations were performed in IR cardiac
cells subjected to the same pre- and posttreatments with 25 μM
Trolox, the concentration required to obtain the same antioxidant
capacity of 10 μM curcumin. In addition, treatments with Bay 11–7082
and SP600125, used at proper concentrations, were performed to
explore, even from a quantitative point of view, the roles of NF-κB and
JNK in the outcome of IR cells and the effects of curcumin and Trolox
on these pathways.
From the obtained results it seems that the IR conditions realized
in the present studywere associatedwith a patent oxidative stress and
resulted in impaired cell viability, as judged by the MTT reduction test.
At the same time, the increase in the ratio of released to total LDH,
which was about 10-fold higher with respect to the control values,
indicated a considerable development of the cell death processes. As
for the mode of cell death, the occurrence of apoptosis, in addition to
necrosis, was evident from the results of confocal microscopy analysis
that we performed to assess the outcome of IR cells and caspase
activation. Finally, the observed increases in NF-κB nuclear transloca-
tion and in JNK phosphorylation suggest a significant activation of the
pathways related to these factors and their potential role in the
damages affecting our IR cardiac cells.
A comparative valuation of the various treatments performed in
this study clearly shows that both curcumin and Trolox pretreatments
were more effective than the corresponding posttreatments in
attenuating oxidative stress and in limiting cell injury. This finding
is probably ascribable to the fact that in the posttreatments the
intracellular levels of curcumin and Trolox, despite the quick cellular
absorption of both these compounds, were not high enough to protect
against the burst of ROS production that, as stated above, occurred
after a few minutes of simulated reperfusion. According to this
interpretation, the apparently contradictory result of a higher total
antioxidant capacity in the posttreated than in the pretreated cells
may simply reflect a reduced consumption of the added antioxidants.If we restrict the comparison to the pretreatments, it is evident
that, although curcumin and Trolox were used at concentrations with
the same scavenging activity and their addition produced similar
levels of total antioxidant capacity in exposed cells, the protective
effects of the two treatments were quite different. Curcumin, in fact,
was significantly more effective than Trolox in preserving the viability
of IR cardiac cells and in reducing total and, in particular apoptotic, cell
death. Taken together, these results suggest that curcumin can provide
a substantial protection against IR injury, not only through its
antioxidant properties but also via other mechanisms, acting at the
biochemical and/or the cellular level. In this context we found that
both NF-κB translocation to the nucleus and JNK phosphorylation,
which are crucial steps in the activation of the pathways involving
these factors, were markedly reduced by curcumin pretreatment of IR
cardiac cells. Other investigators, using different experimental models,
have reported that curcumin inhibits NF-κB- and JNK-related path-
ways and protects cells experiencing oxidative stress or other
stressing agents [30,31]. The novel finding arising from the present
study is that these actions are also partly attributable to the
antioxidant properties of curcumin, because the pretreatment of IR
cells with this compound resulted in an inhibition of NF-κB nuclear
translocation and of JNK phosphorylation that was quantitatively
comparable to that observed, respectively, for Bay 11–7082 and
SP600125 and significantly higher than that induced by Trolox.
This leads us to suppose a direct molecular interaction of curcumin
in the above-mentioned pathways, an interpretation in line with
several, although fragmentary, reports on this subject. Indeed, it has
been reported that curcumin can inhibit IKK [32–34], an essential
enzyme for NF-κB activation, and can induce covalent modifications
affecting NF-κB binding to DNA [35,36]. As for JNK, it has been found
that curcumin may interfere at the proximal upstream portion of this
pathway, in particular at the MAPK kinase kinase level [31]. Moreover,
in light of recent findings indicating a cross talk between NF-κB and
JNK [37], the above-mentioned effects might be independent or
reciprocally related.
In this study a strong indication of the possibility of a direct
interaction of curcumin in the NF-κB and JNK pathways, and of a link
between this event and the protective effect of the agent, was
provided by the comparison of the changes in LDH release observed in
the IR cells pretreated with curcumin and Trolox with those produced
by similar pretreatments with Bay 11–7082 and SP600125.
On one hand, the significant reduction in LDH release obtained
with the two inhibitors confirms that the activation of the NF-κB and
JNK pathways has an important role, even in our model, in the
outcome of the IR cells. On the other hand, the absence of a significant
difference in LDH release between curcumin and Trolox pretreatments
when they were performed in the presence of Bay 11–7082 and
SP600125, that is, under conditions precluding further effects on NF-
κB and JNK, leads us to believe that the higher protection exhibited by
curcumin treatment is due to the greater extent to which it can affect
these pathways, an effect that implies other interactions in addition to
the antioxidant power because, as repeatedly stated, the two
compounds were used at a parity of antioxidant capacity.
In conclusion, the results of this study indicate that a shrewd use of
curcumin may represent a promising approach to protecting cardiac
cells against IR injury. In this scenario our findings point out the
importance of the chronology for the treatment outcome and
represent the first attempt (at least to our knowledge) to differentiate
the degree of protection that curcumin can exert by its antioxidant
activity and by other mechanisms. To better understand the useful-
ness of curcumin in protecting heart from ischemia-reperfusion
injury, our results support the exploration of the effects of this
compound on cardiac cells other than myocytes, a subject of only a
few reports [38,39] in the current literature, and the study of the
feasible molecular interactions with NF-κB, JNK, and other oxidative
stress-dependent pathways potentially involved in apoptotic/necrotic
846 C. Fiorillo et al. / Free Radical Biology & Medicine 45 (2008) 839–846cell death. Interesting information might be so obtained for adjusting
and/or integrating curcumin treatment to optimize the protective
effect, whereas in vivo studies will confirm the reaching of this goal.
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